ERIKA FERNANDEZ: Open Payments
NPI 1275226417 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 63 payments from 18 companies in 2025. Trend: 2023 $206 · 2024 $1,177 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $189 |
| Sumitomo Pharma America, Inc. | 2 | $188 |
| ABBVIE INC. | 10 | $148 |
| AstraZeneca Pharmaceuticals LP | 7 | $128 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| Lilly USA, LLC | 5 | $80 |
| Exact Sciences Corporation | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 7 | $38 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
Products named: GEMTESA, JARDIANCE, Ozempic, UBRELVY, MOUNJARO, FARXIGA, BREZTRI, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
